Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Wigerup

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Pharmacology & Therapeutics|May 4, 2016
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancerCaroline Wigerup, Sven Påhlman, Daniel Bexell
Seminars in Cancer Biology|September 28, 2011
Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stageSofie A Mohlin, Caroline Wigerup, Sven Påhlman
Experimental Cell Research|March 13, 2017
Hypoxia, pseudohypoxia and cellular differentiationSofie Mohlin, Caroline Wigerup, Annika Jögi, et al.
BMC Research Notes|March 23, 2011
Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analysesKristina E Aaltonen, Anna Ebbesson, Caroline Wigerup, et al.
International Journal of Cancer|February 26, 2011
p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patientsMaria Stendahl, Sofie Nilsson, Caroline Wigerup, et al.
Cancer Research|October 4, 2015
PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastomaSofie Mohlin, Arash Hamidian, Kristoffer von Stedingk, et al.
Genes, Chromosomes & Cancer|December 16, 2011
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosisIda Johansson, Kristina E Aaltonen, Anna Ebbesson, et al.
Experimental Cell Research|January 17, 2020
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastomaCamilla U Persson, Kristoffer von Stedingk, Elina Fredlund, et al.
Cancer Research|February 3, 2012
Tumor-initiating cells in childhood neuroblastoma--letterSofie Mohlin, Alexander Pietras, Caroline Wigerup, et al.
Biochemical and Biophysical Research Communications|February 8, 2014
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferationSusann Reinbothe, Anna-Maria Larsson, Marica Vaapil, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Pharmacology & Therapeutics|May 4, 2016
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancerCaroline Wigerup, Sven Påhlman, Daniel Bexell
Seminars in Cancer Biology|September 28, 2011
Neuroblastoma aggressiveness in relation to sympathetic neuronal differentiation stageSofie A Mohlin, Caroline Wigerup, Sven Påhlman
Experimental Cell Research|March 13, 2017
Hypoxia, pseudohypoxia and cellular differentiationSofie Mohlin, Caroline Wigerup, Annika Jögi, et al.
BMC Research Notes|March 23, 2011
Laser capture microdissection (LCM) and whole genome amplification (WGA) of DNA from normal breast tissue --- optimization for genome wide array analysesKristina E Aaltonen, Anna Ebbesson, Caroline Wigerup, et al.
International Journal of Cancer|February 26, 2011
p27Kip1 is a predictive factor for tamoxifen treatment response but not a prognostic marker in premenopausal breast cancer patientsMaria Stendahl, Sofie Nilsson, Caroline Wigerup, et al.
Cancer Research|October 4, 2015
PI3K-mTORC2 but not PI3K-mTORC1 regulates transcription of HIF2A/EPAS1 and vascularization in neuroblastomaSofie Mohlin, Arash Hamidian, Kristoffer von Stedingk, et al.
Genes, Chromosomes & Cancer|December 16, 2011
Increased gene copy number of KIT and VEGFR2 at 4q12 in primary breast cancer is related to an aggressive phenotype and impaired prognosisIda Johansson, Kristina E Aaltonen, Anna Ebbesson, et al.
Experimental Cell Research|January 17, 2020
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastomaCamilla U Persson, Kristoffer von Stedingk, Elina Fredlund, et al.
Cancer Research|February 3, 2012
Tumor-initiating cells in childhood neuroblastoma--letterSofie Mohlin, Alexander Pietras, Caroline Wigerup, et al.
Biochemical and Biophysical Research Communications|February 8, 2014
EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferationSusann Reinbothe, Anna-Maria Larsson, Marica Vaapil, et al.
Pageof 2